Helix BioPharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
21 Aug 23 | BuyUS$368,781 | Jerzy Wilczewski | Individual | 2,777,778 | US$0.13 | |
21 Aug 23 | BuyUS$53,104 | Jerzy Leszczynski | Individual | 400,000 | US$0.13 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 26,363,172 | 11.5% |
Individual Insiders | 39,219,875 | 17.1% |
General Public | 163,858,036 | 71.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
33,944,931 | US$4.7m | 0% | no data | |||
26,363,172 | US$3.7m | 0% | 0.83% | |||
3,191,600 | US$443.1k | 0% | no data | |||
2,083,344 | US$289.2k | 0% | no data |